CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in SPRY — ARS Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in SPRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,283,153
-$2,135,204 QoQ
Shares Held
533,394
-3.2% QoQ
Ownership
0.537%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. SPRY ranks #141 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in SPRY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,283,153 | 533,394 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,418,357 | 550,932 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,233,617 | 520,758 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $7,716,424 | 442,202 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,241,545 | 416,657 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $4,509,882 | 427,477 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $6,147,231 | 423,947 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,536,160 | 415,530 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,528,914 | 345,295 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,805,934 | 329,550 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,226,243 | 324,403 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $479,793 | 71,611 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $105,266 | 16,170 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $137,930 | 16,170 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $451,195 | 106,414 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $517,286 | 147,375 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $991,960 | 148,943 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,388,267 | 139,105 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,650,485 | 85,804 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,682,939 | 84,413 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||